711 HBM1022, a novel anti-CCR8 antibody depletes tumor-infiltrating regulatory T cells via enhanced ADCC activity, mediates potent anti-tumor activity with Keytruda

oleh: Yun He, Juan Liu, Fei Chen, Yang Cao, Yuntao Wu, Lei Niu, Shuang Lu, Shaoping Hu, Xin Gan, Yongqiang Wang, Chuchu Zhao, Yi Ding, Jinqiu He, Qing Du, Xiaocheng Lv, Beibei Qin, Yuandong Wang, Yunxing Yang, Musheng Bao, Jason Noon, Wenhao Yu, Joe Zhao, Yiping Rong

Format: Article
Diterbitkan: BMJ Publishing Group 2020-11-01

Deskripsi

No description available for this item.